New Indication Approval Case Study: Victoza of Novo Nordisk A/S
Posted on29 Aug 2017
TagsEli Lilly launched Trulicity, GLP1-agnostics, new indication approval, Novo nordisk, Trulicity, Victoza
Comments0
Novo Nordisk A/S got approval of a new, heart-focused indication for its Victoza – diabetes medicine. This will help Novo Nordisk to... Read More
Eli Lilly launched Trulicity (dulaglutide), once-a-week drug for type 2 diabetes, in India
Eli Lilly and Company (India) Pvt. Ltd. today announced the launch of its recently approved diabetes treatment Trulicity (dulaglutide) in India. Trulicity... Read More